Tvardi Therapeutics, Inc. (TVRD): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$19.35M
Year ended 2024-12-31
$2.82M2013-12-31: $2.82M2014-12-31: -$17.68M2015-12-31: -$21.50M2016-12-31: -$48.10M2017-12-31: -$54.88M2018-12-31: -$22.37M2019-12-31: -$109.24M2020-12-31: -$5.84M2021-12-31: -$60.13M2022-12-31: -$78.77M2023-12-31: -$94.45M2024-12-31: -$19.35M-$19.35M
2013-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$19.35Mn/m2026-03-31, From 2024-01-01
2023-12-31-$94.45Mn/m2025-03-11, From 2023-01-01
2022-12-31-$78.77Mn/m2025-03-11, From 2022-01-01
2021-12-31-$60.13Mn/m2024-03-06, From 2021-01-01
2020-12-31-$5.84Mn/m2023-03-06, From 2020-01-01
2019-12-31-$109.24Mn/m2022-03-01, From 2019-01-01
2018-12-31-$22.37Mn/m2021-02-25, From 2018-01-01
2017-12-31-$54.88Mn/m2020-02-27, From 2017-01-01
2016-12-31-$48.10Mn/m2019-03-12, From 2016-01-01
2015-12-31-$21.50Mn/m2018-03-15, From 2015-01-01
2014-12-31-$17.68Mn/m2017-03-10, From 2014-01-01
2013-12-31$2.82Mn/a2016-03-11, From 2013-01-01